Sanofi’s latest analysis of Rezurock can inform future research, company saysnews2022-04-21T13:10:00+00:00April 21st, 2022|Fierce Pharma|
Enzyvant to build regenerative medicine manufacturing plant in North Carolinanews2022-04-21T12:55:02+00:00April 21st, 2022|Fierce Pharma|
AstraZeneca’s Evusheld offers at least 6 months of COVID protection in high-risk patients, study findsnews2022-04-21T12:33:19+00:00April 21st, 2022|Fierce Pharma|
Eli Lilly takes to social media for a personal touch to its Alzheimer’s campaignnews2022-04-21T08:40:12+00:00April 21st, 2022|Fierce Pharma|
J&J, Endo and McKesson settle Alabama opioid litigation for $276Mnews2022-04-20T17:33:24+00:00April 20th, 2022|Fierce Pharma|
Sanofi tees off work on €400M ‘factory of the future’ in Singaporenews2022-04-20T17:25:19+00:00April 20th, 2022|Fierce Pharma|
GlaxoSmithKline manufacturing staffers in UK vote to strike over ‘derisory’ pay raise offernews2022-04-20T15:04:59+00:00April 20th, 2022|Fierce Pharma|
Seagen plots new biologics plant to amp up antibody drug productionnews2022-04-20T15:02:25+00:00April 20th, 2022|Fierce Pharma|
FDA swats back Teva, MedinCell’s long-acting schizophrenia drug applicationnews2022-04-20T15:00:44+00:00April 20th, 2022|Fierce Pharma|
Merck vet Romanelli returns as international human health chief after brief stint as CEO at Chinese drugmakernews2022-04-20T13:15:56+00:00April 20th, 2022|Fierce Pharma|
